News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Biodel Inc. Reports Fourth Quarter Fiscal Year 2012 Financial Results
December 18, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
DANBURY, Conn., Dec. 18, 2012 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) today reported financial results for the fourth fiscal quarter ended September 30, 2012.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Mergers & acquisitions
AbbVie sinks talons into KRAS with right to buy Kestrel for up to $1.45B
April 28, 2026
·
1 min read
·
Annalee Armstrong
Layoff Tracker
Novartis cuts hit New Jersey again, affecting 60 employees
April 28, 2026
·
51 min read
·
BioSpace Editorial Staff
Deals
Lilly, AI biotech Profluent ink $2.25B pact in search of genetic medicine ‘holy grail’
April 28, 2026
·
2 min read
·
Gabrielle Masson
Earnings
Novartis’ sales dip as generics pressure intensifies, radioequivalents loom
April 28, 2026
·
2 min read
·
Tristan Manalac
